4,607 Shares in GE HealthCare Technologies Inc. $GEHC Bought by Petrus Trust Company LTA

Key Points

• Petrus Trust Company LTA has invested approximately $372,000 in GE HealthCare Technologies, acquiring 4,607 shares in the first quarter.
• GE HealthCare Technologies recently reported $1.06 EPS, exceeding analyst expectations of $0.91, with revenue of $5 billion for the quarter.
• The company declared a quarterly dividend of $0.035 per share, reflecting a modest yield of 0.2%.

Petrus Trust Company LTA bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,607 shares of the company's stock, valued at approximately $372,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of GEHC. N.E.W. Advisory Services LLC purchased a new position in shares of GE HealthCare Technologies in the 1st quarter worth $25,000. Bogart Wealth LLC lifted its position in GE HealthCare Technologies by 260.0% during the first quarter. Bogart Wealth LLC now owns 342 shares of the company's stock valued at $28,000 after purchasing an additional 247 shares during the period. Stonebridge Financial Group LLC lifted its stake in shares of GE HealthCare Technologies by 165.7% in the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock valued at $29,000 after purchasing an additional 222 shares during the period. Ameriflex Group Inc. acquired a new position in GE HealthCare Technologies during the fourth quarter worth $31,000. Finally, Olde Wealth Management LLC purchased a new stake in shares of GE HealthCare Technologies in the first quarter valued at about $35,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Down 1.9%

GE HealthCare Technologies stock traded down $1.50 during midday trading on Friday, reaching $76.46. The stock had a trading volume of 2,334,690 shares, compared to its average volume of 3,962,065. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80. The firm's fifty day simple moving average is $74.45 and its 200-day simple moving average is $73.76. The stock has a market capitalization of $34.91 billion, a P/E ratio of 15.68, a price-to-earnings-growth ratio of 2.90 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping analysts' consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The company had revenue of $5 billion for the quarter, compared to analysts' expectations of $4.96 billion. During the same quarter last year, the business earned $1.00 earnings per share. GE HealthCare Technologies's revenue was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 25th were given a $0.035 dividend. The ex-dividend date was Friday, July 25th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies's payout ratio is 2.87%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on GEHC shares. Citigroup lifted their price target on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a research note on Thursday, July 31st. Zacks Research raised shares of GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research report on Thursday, August 28th. Morgan Stanley dropped their price target on GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating on the stock in a research report on Thursday, July 31st. Wall Street Zen raised GE HealthCare Technologies from a "hold" rating to a "buy" rating in a report on Saturday, May 31st. Finally, BTIG Research reaffirmed a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, GE HealthCare Technologies has an average rating of "Moderate Buy" and an average price target of $88.40.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.